Guardant Health, Inc. (GH)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Guardant Health, Inc. reported revenue of $982.02M, up 32.9% from the prior year. The company ran a net loss, with a net margin of -42.4%. It held $2.01B in total assets against $2.11B in total liabilities.
Key ratios (FY2025)
-44.5%
Operating margin
-42.4%
Net margin
+32.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $982.02M | $739.02M | $563.95M | $449.54M | $373.65M | $286.73M | $214.38M | $90.64M | $49.84M | — |
| Cost of Revenue | $349.01M | $289.80M | $227.05M | — | — | — | — | — | — | — |
| Operating Income | -$437.25M | -$443.59M | -$564.73M | -$544.38M | -$411.00M | -$254.95M | -$82.37M | -$92.94M | -$76.61M | — |
| Net Income | -$416.28M | -$436.37M | -$479.45M | -$654.59M | -$384.77M | — | -$75.65M | -$85.06M | -$83.22M | — |
| EPS (Diluted) | $-3.32 | $-3.56 | $-4.28 | $-6.41 | $-4.00 | $-2.60 | $-0.84 | — | — | — |
| Total Assets | $2.01B | $1.49B | $1.79B | $1.61B | $2.20B | $2.27B | $962.53M | $587.40M | — | — |
| Total Liabilities | $2.11B | $1.63B | $1.63B | $1.55B | $1.56B | $916.19M | $114.54M | $62.45M | — | — |
| Shareholders' Equity | -$99.31M | -$139.65M | $158.68M | $60.18M | $645.00M | $1.30B | $798.39M | $483.15M | $308.61M | $79.70M |
| Cash & Equivalents | $378.20M | $525.54M | $1.13B | $141.65M | $492.20M | $832.98M | $143.23M | $140.54M | — | — |
| Operating Cash Flow | -$184.76M | -$239.86M | -$324.98M | -$309.46M | -$209.02M | -$103.93M | -$47.13M | -$72.19M | -$72.23M | — |
| Capital Expenditures | $48.31M | $35.09M | $20.49M | $77.46M | $75.03M | $36.17M | $18.72M | $20.20M | $6.68M | — |
| Shares Outstanding | 130.64M | 123.99M | 121.63M | 102.62M | 101.77M | 100.21M | 94.26M | 85.83M | — | — |